Observing the safety of phage therapy for serious infections

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This cohort study aims to document adverse events associated with the use of bacteriophages in treating serious infections, particularly prosthetic joint infections. It will collect data on potential serious adverse events from compassionate cases and classify them based on their relation to surgery, antibiotics, or phage therapy. Additionally, blood specimens will be biobanked before and after treatment to investigate any immunological responses related to phage therapy.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patient 18 years of age or older with a serious infection treated at CRIOAc Lyon by phage therapy
* Patient who did not object to participating in the study
* Patients ayant un poids minimum de 46kg

Exclusion Criteria:

* Patients under guardianship/curatorship
* Patients deprived of liberty
* Pregnant or breastfeeding women

Where it's running

• Hospices Civils de Lyon
  Lyon, France Recruiting

Study contacts

• Study coordinator: Johanna Boulant, CRA
• Email: johanna.boulant@chu-lyon.fr
• Phone: 04 26 73 29 38

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• How knee and hip joint replacements are doing over time

  This observational study follows adults who have knee or hip replacements to see how their outcomes look over time after the surgery.

  Recruiting University Hospital, Bonn · Bonn, North Rhine-Westphalia · NCT07799818

• Population pharmacokinetics of rifampicin in staphylococcal osteoarticular infections

  This study tests how rifampicin behaves in the body of adults with staphylococcal osteoarticular infections when given with levofloxacin or ciprofloxacin, to see how drug exposure relates to tolerance and outcomes.

  Recruiting Groupe Hospitalier Diaconesses Croix Saint-Simon · Paris, Paris · NCT07788404

• Infectious complications in blood cancer patients treated with bispecific antibodies

  This study tests how often infections occur in adults with blood cancers who are being treated with bispecific antibodies.

  Recruiting at 2 sites Infanta Leonor University Hospital · Madrid, Madrid and 1 other locations · NCT07609576

• Reducing bacterial contamination during primary shoulder replacement

  This trial tests whether putting Prontosan antimicrobial gel on the dermal layer after the skin is cut can lower Cutibacterium acnes growth in men having primary shoulder replacement.

  Recruiting St. Louis University · St Louis, Missouri · NCT07406893

• Methylene blue dye to measure how much irrigation clears contamination during knee replacement procedures

  We will test whether putting methylene blue dye into the knee during replacement or DAIR procedures can show how much irrigation is needed to wash out contaminants.

  Recruiting Phase 1 University of Miami · Miami, Florida · NCT07324954

• N-acetylcysteine for severe infection with liver dysfunction in adults

  In adults with acute infection or sepsis and liver dysfunction, this study tests whether giving N-acetylcysteine in a four-hour infusion improves days alive and out of the hospital in the first 14 days.

  Recruiting Phase 4 University Hospital Bispebjerg and Frederiksberg · Copenhagen · NCT07273071

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.